Opioid prescribing patterns have come under increased scrutiny in the setting of the ongoing opioid epidemic as rates of opioid prescription, overdose, and mortality have risen in the United States.1 The opioid epidemic has appropriately led to new guidelines, regulations, and policies that attempt to curtail the inappropriate use of opioids in clinical practice. However, these policies in part arise from prior research of opioid-related adverse effects in the noncancer population, and we lack an understanding of how the opioid epidemic and related opioid policies will influence patients with cancer.
Vitzthum LK, Riviere P, Murphy JD. Managing Cancer Pain During the Opioid Epidemic—Balancing Caution and Compassion. JAMA Oncol. Published online May 07, 2020. doi:10.1001/jamaoncol.2020.0779
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: